Prevalência de determinantes maternos associados ao uso de medicamentos por classe de risco na gravidez

Abstract

INTRODUCTION: In view of the full rights to maternal and child health, prenatal monitoring quality is a preventive action for the mother and fetus. Among the attitudes established as essential to the development of quality of prenatal care, there is also guidance on the use of medicines in this period. However, the occurrence of pregnancy is influenced by changes in the body, being common drug therapy to treat manifestations associated tooth period and to maintain desirable patterns of fetal development. The use of medications during pregnancy requires careful evaluation, the Food and Drug Administration (FDA - United States) classifies drugs according to the risk associated with the use during pregnancy and falls into five categories: A, B, C, D and X, and the last three mentioned categories should be avoided in principle. OBJECTIVES: To characterize pregnant women who used drugs in terms of sociodemographic and health, identify the drugs most used and the most prevalent maternal determinants for consumption of drugs classified in C, D and X. METHODS: A cross-sectional, exploratory, part of a research "Maternal risk factors for low birth weight, prematurity and growth retardation intrauterine in Reconcavo of Bahia". The population consisted of pregnant women registered in USF Santo Antônio de Jesus, from August January-December 2012, corresponding to 296 women. Were developed descriptive analyzes of the characteristics of interest in the study by use of univariate and bivariate tables and descriptive measures. To check for differences between proportions was used statistical test χ2 Fischer Exact considering a confidence level of 95% (α ≤ .05). The project had Committee approval Ethics the Faculty Adventist of Physiotherapy (FAFIS), looking at fundamental aspects's ethical Resolution 196/96. In statistical analysis of data was used the STATA™ version 8.2. RESULTS: We found statistically significant differences between drug consumption C, D and X and practices alcoholics, smokers and early prenatal care. CONCLUSIONS: Medicines C, D and X exert negative influence on pregnancy, revealing the need for reassessment of its safety by the National Agency for Sanitary Surveillance (ANVISA). It is worth mentioning the role of (the) s ESF professionals in the reorganization of practices guided by the facilitators to prenatal care and maternal and child health, emphasizing the nurse's role in this process.